(NASDAQ: IOSP) Innospec's forecast annual revenue growth rate of 3.74% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.58%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 19.3%.
Innospec's revenue in 2026 is $1,842,100,000.On average, 5 Wall Street analysts forecast IOSP's revenue for 2026 to be $47,069,930,817, with the lowest IOSP revenue forecast at $44,138,836,224, and the highest IOSP revenue forecast at $49,089,676,671.
In 2027, IOSP is forecast to generate $49,902,501,222 in revenue, with the lowest revenue forecast at $46,478,785,689 and the highest revenue forecast at $52,316,343,828.